Sign in

CIK 0000879407 · Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
460408024
Phone
626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Grant or award Director acquired 14,987 shares (grant or award)
  2. 4 Grant or award Director acquired 14,987 shares (grant or award)
  3. 4 Grant or award Director acquired 14,987 shares (grant or award)
  4. 4 Grant or award Director acquired 14,987 shares (grant or award)
  5. 4 Grant or award Director acquired 14,987 shares (grant or award)
  6. 4 Planned sale Chief Medical Officer sold 19,700 shares at an average $28.80 ($567,315)
  7. 4 Planned sale Chief Executive Officer sold 24,338 shares at $24.21 ($589,223)
  8. 4 Open-market sale Director sold 1,550 shares at $26.33 ($40,812)
  9. 4 Open-market sale Chief Executive Officer sold 57,755 shares at an average $28.12 ($1,624,223)
  10. 4 Open-market sale Chief Commercial Officer sold 8,925 shares at $35.31 ($315,142)
  11. 4 Open-market sale Chief Discovery/Trans Medicine sold 3,000 shares at $35.53 ($106,590)
  12. 4 Open-market sale Chief Financial Officer sold 15,000 shares at $36.20 ($543,000)
  13. 4 Open-market sale Director sold 6,500 shares at $40.90 ($265,850)
  14. 4 Open-market sale Chief Executive Officer sold 104,928 shares at an average $39.32 ($4,125,674)
  15. 4 Open-market sale Director sold 11,350 shares at $32.65 ($370,578)
  16. 4 Open-market sale Director sold 875 shares at $32.62 ($28,543)
  17. 4 Grant or award Director acquired 7,867 shares (grant or award)
  18. 4 Grant or award Director acquired 7,867 shares (grant or award)
  19. 4 Grant or award Director acquired 7,867 shares (grant or award)
  20. 4 Grant or award Director acquired 7,867 shares (grant or award)

Page 5 of 25 · 497 filings